Samsung Secures FDA Approval for Sleep Apnea Detection Feature on Galaxy Watch

Samsung has attained FDA approval for its sleep apnea detection feature on the Galaxy Watch, set to release in the U.S. Later this 12 months. This groundbreaking approval marks Samsung because the first organization to acquire FDA clearance for smartwatch-based sleep apnea detection, following comparable approval from the South Korean government in October 2023.

Sleep apnea, a continual circumstance characterized by way of interrupted respiration in the course of sleep, poses extensive health risks such as cardiovascular disorder. Despite its prevalence—25% of men and 10% of girls within the U.S. Are affected—many cases go undiagnosed because of the condition occurring at some point of sleep.

While Samsung's genuine detection method remains undisclosed, the Galaxy Watch is ready to screen common symptoms of sleep apnea, which includes fluctuations in blood oxygen saturation or coronary heart charge in the course of sleep. Users sporting their Galaxy Watch to mattress could be monitored for sleep apnea after two nights within a 10-day period. Data accrued from those tests can be accessed through the Samsung Health Monitor app, with users receiving notifications if signs of sleep apnea are detected.

Although this option serves as a valuable addition to the Galaxy Watch's healthcare abilties, it is important to note that it is FDA authorized simplest for individuals aged 22 and older and isn't always meant for the ones already diagnosed with sleep apnea.

Looking beforehand, Samsung targets to release the sleep apnea detection feature for Galaxy Watch five and Galaxy Watch 6-collection gadgets in Q3, possibly debuting all through the Galaxy Unpacked occasion in August. With this innovative step, Samsung leads the way in leveraging smartwatch technology to decorate proactive healthcare.